# Diamond Medino Capital

> Diamond Medino Capital is a VC fund in Tokyo backing Manufacturing and Pharmaceutical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 7
- Last investment: Sep 2025
- Lead investor: 43%
- Last updated: Aug 2026
- Website: https://diamondmedino.com

Diamond Medino Capital is a VC fund in Tokyo focused on Manufacturing and Pharmaceutical. Diamond Medino Capital offers services that revolutionize health care and society.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $854k–$7.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 2 | 29% |
| Pharmaceutical | 2 | 29% |
| Medical | 1 | 14% |
| Robotics | 1 | 14% |
| Health Care | 1 | 14% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 43% |
| Series B | 1 | 14% |
| Venture - Series Unknown | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| FerroptoCure | FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases. | $3.1M | Series A | Sep 19, 2025 |  |
| Global Vascular | Global Vascular is an deep-tech firm focused on creating a stent designed to minimize foreign body reactions, utilizing a technological platform developed through a collaboration between medical and engineering experts. The company seeks to achieve early pharmaceutical approval to facilitate the restoration of blood circulation in the legs ofpatients suffering from peripheral arterial disease, who experience walking difficulties and need prompt intervention. | $19.3M | Series B | Jun 30, 2025 |  |
| Spine Chronicle | Spine chronicle is a medical device manufacturing firm that specializes in developing orthopedic medical equipment. | $854.2K | Series A | Jan 14, 2025 |  |
| F.MED | F.MED is a manufacturing company that designs and develops robotic microsurgical devices for the healthcare industry. | $2.7M | Series A | Jul 08, 2024 |  |
| StapleBio | StapleBio is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology. | $3M | Venture - Series Unknown | Apr 01, 2024 |  |
| Global Vascular | Global Vascular is an deep-tech firm focused on creating a stent designed to minimize foreign body reactions, utilizing a technological platform developed through a collaboration between medical and engineering experts. The company seeks to achieve early pharmaceutical approval to facilitate the restoration of blood circulation in the legs ofpatients suffering from peripheral arterial disease, who experience walking difficulties and need prompt intervention. | $7.9M | Series A | Dec 05, 2023 |  |
| Global Vascular | Global Vascular is an deep-tech firm focused on creating a stent designed to minimize foreign body reactions, utilizing a technological platform developed through a collaboration between medical and engineering experts. The company seeks to achieve early pharmaceutical approval to facilitate the restoration of blood circulation in the legs ofpatients suffering from peripheral arterial disease, who experience walking difficulties and need prompt intervention. | $1.9M | Seed | May 10, 2023 |  |

7 of 7 investments shown.

## Co-investors
- [TUSIC](https://shizune.co/investors/profile/tusic) — VC Fund, 5 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 4 deals together
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 3 deals together
- [Higin Capital](https://shizune.co/investors/profile/higegin-capital) — VC Fund, 2 deals together
- [Tokyo University of Science Investment Management](https://shizune.co/investors/profile/tokyo-university-of-science-investment-management) — VC Fund, 2 deals together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does Diamond Medino Capital invest in?

Diamond Medino Capital invests primarily in Manufacturing, Pharmaceutical and Medical startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Diamond Medino Capital's check size?

Diamond Medino Capital typically joins rounds of $854k–$7.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Diamond Medino Capital participates in.

### When did Diamond Medino Capital last invest?

The most recent investment recorded for Diamond Medino Capital closed in Sep 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co